AQE

Microsoft and 1910 Genetics Partner to Build the Infrastructure Layer for Drug Discovery and Development Using AI and High-Performance Computing

Retrieved on: 
Thursday, February 29, 2024
Research, General Health, Pharmaceutical, Technology, Artificial Intelligence, Genetics, Health Technology, Science, Biotechnology, Other Technology, Other Science, Health, Therapy, HPC, Doctor of Philosophy, Multimedia, Artificial intelligence, Chemistry, AI, Neuroscience, Drug development, Drug discovery, Government, Playground Global, Learning, Observation, AQE, Automation, Infection, Potential, Corporation, Microsoft, Robotics, Observational comedy, Lithium, Cancer, Partnership, Pharmaceutical industry

1910 will offer the platform to pharmaceutical, biotechnology, government, academic, and research institutions via three partnership models: Co-discovery, Co-engineering, and Platform-as-a-Service.

Key Points: 
  • 1910 will offer the platform to pharmaceutical, biotechnology, government, academic, and research institutions via three partnership models: Co-discovery, Co-engineering, and Platform-as-a-Service.
  • “We are thrilled to be collaborating with 1910 Genetics to bring their pioneering AI drug discovery engines to Azure Quantum Elements,” said Jason Zander, Executive Vice President of Strategic Missions and Technologies at Microsoft.
  • Our collaboration with 1910 Genetics demonstrates our shared commitment to innovation and our aspiration to solve some of the most challenging problems the world faces in drug discovery.
  • AI offers an unprecedented opportunity to compress these cycles, accelerate the time from observation to discovery, and reduce the need for experimentation.

NobleAI Announces Groundbreaking Collaboration with Microsoft Azure Quantum Elements

Retrieved on: 
Wednesday, October 25, 2023
Chemical substance, Freedom, Microsoft, HPC, Research, R, AQE, Informatics, CPU, AI, Chemistry, D, SAN, Medical device, Fine chemical

SAN FRANCISCO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- NobleAI , a pioneer in Science-Based AI solutions for Chemical and Material Informatics, today announced a first-of-its-kind collaboration with Azure Quantum Elements (AQE) – a cloud-based service from Microsoft that accelerates scientific discovery by integrating the latest breakthroughs in High-Performance Computing (HPC), AI, and quantum computing.

Key Points: 
  • SAN FRANCISCO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- NobleAI , a pioneer in Science-Based AI solutions for Chemical and Material Informatics, today announced a first-of-its-kind collaboration with Azure Quantum Elements (AQE) – a cloud-based service from Microsoft that accelerates scientific discovery by integrating the latest breakthroughs in High-Performance Computing (HPC), AI, and quantum computing.
  • The benefits of this collaboration span four key areas:
    Faster time-to-discovery – NobleAI’s Science-Based AI combined with the computational power of Azure Quantum Elements helps expedite product development life cycles exponentially.
  • “Azure Quantum Elements aims to compress 250 years of chemistry into the next 25,” said Dr. Nathan Baker, Product Manager of Azure Quantum Elements.
  • Our collaboration with NobleAI marks an exciting next step in the Azure Quantum Elements journey as we empower chemical and materials scientists with tools that can help them rapidly scale and speed up their research efforts.”